NEW BRUNSWICK, NJ: The Johnson & Johnson's communications and public relations staff will likely be unaffected by the company's announcement that it plans to reduce its global workforce by as much as four percent through the elimination of nearly 4,820 positions, a company spokesman said.
The fourth largest drug company in the US said the cuts will primarily target its pharmaceuticals segments as well as its Cordis stent unit, and are expected to save the company up to $1.6 billion next year.
Jeff Leebaw, VP of corporate media relations, said last Tuesday's announcement was handled internally and that none of the PR agencies the company regularly works with were involved in the internal and media relations efforts that took place.
Leebaw said the company first issued a press release, which was followed up by a conference call for analysts and media that was run by the communications team. Leebaw said the communications team has since been consistently responding to media requests.
The company is facing a significant number of patent expirations over the next few years. That factor, coupled with lagging sales, forced the company to cut costs, according to analysts. Johnson & Johnson produces contraceptives, contact lenses, prescription drugs and baby products.